NCT04718194

Brief Summary

This study is a 2-arm RCT that will assess the efficacy of a culturally adapted, 10-session SGM-affirmative, internet-based cognitive behavioral therapy (iCBT) among young men who have sex with men (YMSM) in Hunan province China. The affirmative treatment called ESTEEM is based on a minority stress-focused, CBT framework. In collaboration with colleagues at Central South University (CSU), the investigators will assess whether a culturally adapted version of iCBT ESTEEM demonstrates significant reductions in HIV risk behavior and mental health symptoms (e.g., depression, anxiety) compared to self-monitoring of stress and mood.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 22, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

April 19, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

January 17, 2024

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

1.6 years

First QC Date

January 13, 2021

Results QC Date

November 14, 2023

Last Update Submit

February 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Number of Past 90-Day Condomless Anal Sex Acts

    The Timeline Follow-Back (TLFB) assesses retrospective estimates of HIV-related sexual behavior in the past 30 days. The TLFB was originally developed in interview format, but has been adapted as online self-report questionnaire. Participants report on daily partner type (e.g. main, casual), type of sexual behavior (e.g. insertive anal sex, receptive anal sex, oral sex), and condom use. The TLFB has good test-retest reliability, convergent validity, and agreement with collateral reports for HIV-related sexual behavior. Administration time ranges from 10-30 minutes. For this primary outcome measure, condomless anal sex (CAS) with main or casual partners will be determined. The primary comparison will be change in the number of CAS acts from baseline to 8 months post-baseline.

    Baseline, 4 months, 8 months

Secondary Outcomes (17)

  • Change in Number of Past 90-Day Condomless Anal Sex Acts With Casual Partners

    Baseline, 4 months, 8 months

  • Change in Depression

    Baseline, 4 months, 8 months

  • Change in Anxiety

    Baseline, 4 months, 8 months

  • Change in Disordered Alcohol Use

    Baseline, 4 months, 8 months

  • Change in Disordered Drug Use

    Baseline, 4 months, 8 months

  • +12 more secondary outcomes

Other Outcomes (3)

  • Change in Depression Severity

    Baseline, 4 months, 8 months

  • Change in Anxiety Severity

    Baseline, 4 months, 8 months

  • Change in Self-Esteem

    Baseline, 4 months, 8 months

Study Arms (2)

ESTEEM iCBT

EXPERIMENTAL

The online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.

Behavioral: ESTEEM iCBT

Self-monitoring

PLACEBO COMPARATOR

Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks

Behavioral: Self-monitoring control

Interventions

ESTEEM iCBTBEHAVIORAL

The online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.

ESTEEM iCBT

Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks

Self-monitoring

Eligibility Criteria

Age16 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old
  • Live in Hunan province China
  • Current gender identity as male
  • Report past 12-month sex with men
  • Be confirmed HIV-negative upon at-home testing
  • Report past 3-month condomless/PrEP-less anal sex
  • Past-week symptoms of depression or anxiety using the Brief Symptom Inventory-4 cutoff of 2.5 on either the depression subscale, anxiety subscale, or both
  • No past 3-month mental health services of more than 2 visits per month
  • Weekly access to internet on a laptop, desktop, or tablet device
  • Ability to read, write, and speak in Mandarin
  • Provision of informed consent

You may not qualify if:

  • Current active suicidality or homicidality (defined as active intent or concrete plan, as opposed to passive ideation)
  • Evidence of active and untreated mania or psychosis that could interfere with the participant's ability to volitionally consent to research or interfere with their ability to safely and reliably complete research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central South University

Hunan, China

Location

MeSH Terms

Conditions

Sexual Behavior

Condition Hierarchy (Ancestors)

Behavior

Limitations and Caveats

This trial was conducted during the COVID-19 pandemic and associated restrictive policies in China, which might have influenced intervention efficacy in ways unknown, although stress, mental health, and behavioral outcomes such as HIV-transmission-risk behavior have all been documented to have been influenced by the pandemic

Results Point of Contact

Title
Dr. Dani Chiaramonte
Organization
Yale

Study Officials

  • John Pachankis, Ph.D.

    Yale University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2021

First Posted

January 22, 2021

Study Start

April 19, 2021

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

February 16, 2024

Results First Posted

January 17, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measures will be made available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available 12 months after study completion for three years.
Access Criteria
Data access requests from qualified academic investigators for non-commercial research interests will be reviewed by study investigators. Requestors will be required to sign a data access agreement.

Locations